Herantis Pharma: Rights Issue(s) Announced - Redeye

Redeye comments on the news that Herantis has carried out a directed issue and announced the intention to carry out a rights issue worth in total EUR 8.7 million. We give our initial take and will return at a later stage to adjust our fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/837422/herantis-pharma-rights-issues-announced?utm_source=finwire&utm_medium=RSS